Variant | Gene | Disease | Risk Allele | Score vda | Association Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
A | 0.700 | GeneticVariation | CLINVAR | ||||||||||
|
|
A | 0.700 | CausalMutation | CLINVAR | ||||||||||
|
|
A | 0.700 | CausalMutation | CLINVAR | ||||||||||
|
|
C | 0.700 | CausalMutation | CLINVAR | ||||||||||
|
|
A | 0.700 | CausalMutation | CLINVAR | ||||||||||
|
|
G | 0.700 | CausalMutation | CLINVAR | ||||||||||
|
|
C | 0.700 | CausalMutation | CLINVAR | ||||||||||
|
|
A | 0.700 | CausalMutation | CLINVAR | ||||||||||
|
|
G | 0.700 | CausalMutation | CLINVAR | ||||||||||
|
|
T | 0.700 | CausalMutation | CLINVAR | How close are we to therapies for Sanfilippo disease? | 28921412 | 2018 |
|||||||
|
|
T | 0.700 | CausalMutation | CLINVAR | Scoring evaluation of the natural course of mucopolysaccharidosis type IIIA (Sanfilippo syndrome type A). | 17938166 | 2007 |
|||||||
|
|
T | 0.700 | CausalMutation | CLINVAR | Residual activity and proteasomal degradation of p.Ser298Pro sulfamidase identified in patients with a mild clinical phenotype of Sanfilippo A syndrome. | 21671382 | 2011 |
|||||||
|
|
T | 0.700 | CausalMutation | CLINVAR | Late-Onset visceral presentation with cardiomyopathy and without neurological symptoms of adult Sanfilippo A syndrome. | 12687673 | 2003 |
|||||||
|
|
T | 0.700 | CausalMutation | CLINVAR | Mucopolysaccharidosis type IIIA: clinical spectrum and genotype-phenotype correlations. | 21061399 | 2010 |
|||||||
|
|
T | 0.700 | CausalMutation | CLINVAR | Cardiac disease as the presenting feature of mucopolysaccharidosis type IIIA: A case report. | 27896117 | 2014 |
|||||||
|
|
T | 0.700 | CausalMutation | CLINVAR | Sanfilippo syndrome: Overall review. | 25851924 | 2015 |
|||||||
|
|
T | 0.700 | CausalMutation | CLINVAR | Behavioural phenotypes of the mucopolysaccharide disorders: a systematic literature review of cognitive, motor, social, linguistic and behavioural presentation in the MPS disorders. | 23385295 | 2013 |
|||||||
|
|
T | 0.700 | CausalMutation | CLINVAR | Cardiac disease as the presenting feature of mucopolysaccharidosis type IIIA: A case report. | 27896117 | 2014 |
|||||||
|
|
T | 0.700 | CausalMutation | CLINVAR | Residual activity and proteasomal degradation of p.Ser298Pro sulfamidase identified in patients with a mild clinical phenotype of Sanfilippo A syndrome. | 21671382 | 2011 |
|||||||
|
|
T | 0.700 | CausalMutation | CLINVAR | Mucopolysaccharidosis type IIIA: clinical spectrum and genotype-phenotype correlations. | 21061399 | 2010 |
|||||||
|
|
T | 0.700 | CausalMutation | CLINVAR | How close are we to therapies for Sanfilippo disease? | 28921412 | 2018 |
|||||||
|
|
T | 0.700 | CausalMutation | CLINVAR | Behavioural phenotypes of the mucopolysaccharide disorders: a systematic literature review of cognitive, motor, social, linguistic and behavioural presentation in the MPS disorders. | 23385295 | 2013 |
|||||||
|
|
T | 0.700 | CausalMutation | CLINVAR | Sanfilippo syndrome: Overall review. | 25851924 | 2015 |
|||||||
|
|
T | 0.700 | CausalMutation | CLINVAR | Scoring evaluation of the natural course of mucopolysaccharidosis type IIIA (Sanfilippo syndrome type A). | 17938166 | 2007 |
|||||||
|
|
T | 0.700 | CausalMutation | CLINVAR | Late-Onset visceral presentation with cardiomyopathy and without neurological symptoms of adult Sanfilippo A syndrome. | 12687673 | 2003 |